Steven Cohen Abbott Laboratories Call Options Transaction History

Point72 Asset Management, L.P.

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $15.7 Million - $18.5 Million	156,600 Added 767.65%	177,000 $20.2 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $3.2 Million - $3.58 Million	-31,800 Reduced 60.92%	20,400 $2.12 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $4.27 Million - $4.72 Million	39,000 Added 295.45%	52,200 $5.93 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $1.19 Million - $1.46 Million	13,200 New	13,200 $1.45 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $1.47 Million - $1.64 Million	14,600 Added 15.01%	111,900 $12.2 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $2.34 Million - $2.76 Million	-24,200 Reduced 19.92%	97,300 $9.85 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $9.03 Million - $10.6 Million	95,000 Added 358.49%	121,500 $13.3 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $58.5 Million - $70.8 Million	-573,500 Reduced 95.58%	26,500 $2.88 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $32.2 Million - $34.5 Million	600,000	600,000 $34.2 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.